Kusajili – Clinical trials directory

Result of your search per sponsor: Jesper Ekelund, MD-PhD

Woman and Man Max 99 years
Jesper Ekelund, MD-PhD Update Il y a 4 ans

Histamine H2 Antagonism as Adjuvant Therapy in Treatment Resistant Schizophrenia The purpose of the study is to investigate whether blockade of the histamine H2 receptors in the brain will have any beneficial effect on the symptoms of subjects with schizophrenia.

Country Finland
organs None
Specialty None

Closed trial

More information